InvestorsHub Logo
Followers 137
Posts 22805
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 07/09/2015 9:49:50 PM

Thursday, July 09, 2015 9:49:50 PM

Post# of 2205
Think about this!!!

It has been 14 days since the first patient in the third dose cohort of the TT-034 trial has been dosed and now Benitec decides to buy back the hepatitis B gene silencing product.

http://blt.live.hqi.com.au/IRM/Company/ShowPage.aspx/PDFs/1559-10000000/6THPATIENTDOSEDINHEPATITISTRIAL

The hepatitis B gene silencing product is a modified version of the TT-034 silencing product that just silences three different areas of the hepatitis B virus.

Think about this does Benitec know how well the TT-034 third cohort's first patient is already responding? (yes the do)

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News